Streetwise Reports Examines Small-Cap Firm Whose Livestock Feed Antibiotic Replacement Enters Large US Market SAN FRANCISCO, March 13, 2019 (GLOBE NEWSWIRE) -- Canada-based Avivagen Inc.'s (VIV:TSX.V) proprietary OxC-beta™ Livestock premix for livestock feeds is a non-antibiotic means of maintaining optimal...

Streetwise Reports Examines Why This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, Is the Pick of Three Fund Managers SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (VIV:TSX.V), a biotech company focused on science-based, natural health products for livestock, companion animals and humans, is making...